Beijing Suncadia Pharmaceuticals Co., Ltd
Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS7
PHASE 3 / 2-34
RECRUITING5
READOUTS ≤12 MONTHS4
| TRIAL | PHASE | STATUS | CONDITION | N | PRIMARY COMPLETION |
|---|---|---|---|---|---|
| SHR-1918 NCT07133815 |
P2 | Not yet recruiting | Homozygous Familial Hypercholesterolemia | 55 | 2025-12 |
| NCT07349615 NCT07349615 |
P3 | Active, not recruiting | Hypertriglyceridemia | 367 | 2027-03 |
| HRS-4029 NCT07739160 |
P2 | Recruiting | Acute Ischemic Stroke | 340 | 2027-04 |
| HRS8179 injection NCT06732648 |
P2/3 | Recruiting | Severe Cerebral Edema Following Large Hemispheric Infarction | 725 | 2027-06 |
| SHR-1918 NCT07230730 |
P3 | Recruiting | Hyperlipidemia | 900 | 2027-10 |
| SHR-1918 Injection NCT07404553 |
P2/3 | Recruiting | Hypercholesterolemia | 126 | 2028-07 |
| SHR-8203 Injection NCT07769242 |
P1/2 | Recruiting | Solid Tumors | 200 | 2029-12-30 |